Page 47 - Read Online
P. 47

Cangemi et al. Mini-invasive Surg 2022;6:3  https://dx.doi.org/10.20517/2574-1225.2021.99  Page 9 of 13

               Table 3. Features of the main studies on hybrid approach, percutaneous coronary intervention, and surgical aortic valve replacement
               treatment
                             Number   PCI to surgery   PCI vessels                               In-hospital
                             of                   and type of   Valve   Type of surgery Complications
                             patients  (Time)     intervention                                   mortality
                Santana et al. [74]  123  39 days (median) LAD (48%)   SAVR (123)  Right anterior   Blood transfusion  30-day
                                                  LAD prox (27.6        thoracotomy  41,         mortality 2
                                                  %)                                 Reoperation for   (1.6%)
                                                  LCX (32.5%)                        bleeding 1,
                                                  RCA (33.3%)                        Stroke 1,
                                                  RI (0.8%)                          Dialysis 2
                                                  Diagonal (5.7%)
                                                  PCI 121
                                                  POBA 2
                Brinster et al. [75]  18  < 1 day   LAD (61%)   SAVR (18)  Right anterior   8 blood   1
                                     (12, same day but  LCX (27%)       thoracotomy  transfusions,
                                     two stages)  RCA (17%)                          1 stroke
                                                  PCI 18
                                                  POBA 0
                George et al. [76]  26  Simultaneously   Valve-PCI:   Reoperative   Primary valve   Blood transfusion  0
                                     (one stage)  RCA (25.7%);   valve-PCI   surgery:   1,
                                                  LCX (29.1%);    patient (14);   Hemisternotomy   Reoperation for
                                                  LM (15.6%)   Primary valve   (2)   bleeding 1,
                                                  LAD prox   surgery (12) of  Sternotomy (10)   Stroke 1
                                                  (10.6%)    these
                                                  LAD mid distal   SAVR (11)  Reoperative valve
                                                  (32.2%)               surgery:
                                                                        Sternotomy (13)
                                                                        Right thoracotomy
                                                                        (1)

               LAD: Left anterior descending; LCX: left circumflex; LM: left main; PCI: percutaneous intervention; POBA: plain old balloon angioplasty; RCA: right
               coronary artery; RI: ramus intermedius; SAVR: surgical aortic valve replacement ; SVG: saphenous vein grafts.


               research. The timing of PCI in TAVI candidates should be established considering the complexity of the
               coronary anatomy, type of valve prosthesis, symptoms, and comorbidities of the patient. Furthermore, the
               progressive younger age of patient candidates for TAVI makes the possibility of re-accessing the coronary
               arteries increasingly important. Thus, further studies on increasing coronary re-access after TAVR and best
               timing of PCI in relation to TAVI are necessary. Hybrid procedures may be the best answer in some
               selected patients. The best management of this condition is paradigmatic of the modern cardiology
               approach that is founded on Heart Team decisions. Modern cardiology is evolving towards tailored
               therapies which need collaboration among medical specialties that were once divided.

               DECLARATIONS
               Authors’contributions
               Conception and design: Cangemi S
               Drafting the article: Cangemi S
               Final approval of the version to be published: Bianchini F, Trani C
               Analysis and interpretation: Romagnoli E, Bruno P
               Data collection: Burzotta F, Nesta M
               Critical revision of the article: Aurigemma C

               Availability of data and materials
               Not applicable.
   42   43   44   45   46   47   48   49   50   51   52